MYCOTECH PHARMA AS
Operating
Utvikle, distribuere og selge ernæringsprodukter og farmasøytiske
produkter samt tilknyttede tjenester med mer, samt investering i annen
virksomhet.
Netthandel med helsekostprodukter.
Organization
- Chairman of the board
- KC
- Years since formation
- 4 years
- since Mar 23, 2022
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 112,841,220
- 1 share class
- Total number of shareholders
- 11
- 8 companies, 3 persons
- Belongs to group of
Financials
- Total operating income 2025
- 2,737,125
- NOK
- Annual total result 2025
- -25,222,767
- NOK
- Total equity 2025
- 12,680,425
- NOK
Last update: Jun 27, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
KC | Chairman | 1.21 % indirectly |
FM 1968 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
FM 1968 | - | 35.34 % indirectly |
KØ 1968 | - | 23.73 % indirectly |
ST 1958 | - | 1.57 % indirectly |
HN | - | 1.41 % indirectly |
KC | Chairman | 1.21 % indirectly |
Last update: Jul 1, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 110,330,000 | 97.77 % | |
| Ordinary shares | 770,000 | 0.68 % | |
| Ordinary shares | 770,000 | 0.68 % | |
| Ordinary shares | 256,410 | 0.23 % | |
| Ordinary shares | 165,000 | 0.15 % | |
| Ordinary shares | 165,000 | 0.15 % | |
RM | Ordinary shares | 128,205 | 0.11 % |
SO 1966 | Ordinary shares | 110,000 | 0.1 % |
| Ordinary shares | 64,105 | 0.06 % | |
| Ordinary shares | 55,000 | 0.05 % | |
| Ordinary shares | 27,500 | 0.02 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 18,004,610Operating profit 2025: NOK -20,461,195Employees: 15
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 2,737,125 | 3,526,886 | 2,033,410 | 1,195,897 |
Annual Total Result | -25,222,767 | -24,831,895 | -18,750,918 | -11,398,297 |
Total assets | 43,968,081 | 55,199,187 | 67,273,250 | 41,953,878 |
Total liabilities | 31,287,656 | 35,041,862 | 52,203,859 | 33,533,996 |
Total equity | 12,680,425 | 20,157,325 | 15,069,392 | 8,419,883 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 2,737,125 | 3,526,886 | 2,033,410 | 1,195,897 |
Total operating costs | 27,873,155 | 33,093,962 | 26,504,833 | 11,895,817 |
Operating result | -25,136,030 | -29,567,077 | -24,471,423 | -10,699,919 |
Financial income/costs | -5,091,982 | -901,411 | -1,443,718 | -698,378 |
Profit before tax | -30,228,012 | -30,468,488 | -25,915,141 | -11,398,297 |
Total tax & extraordinary income/cost | -5,005,245 | -5,636,593 | -7,164,223 | 0 |
Annual Total Result | -25,222,767 | -24,831,895 | -18,750,918 | -11,398,297 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 13,505,374 | 22,728,711 | 29,319,659 | 36,430,906 |
Total current assets | 30,462,707 | 32,470,475 | 37,953,591 | 5,522,972 |
Total assets | 43,968,081 | 55,199,187 | 67,273,250 | 41,953,878 |
Short term debt | 4,679,534 | 8,060,490 | 4,846,464 | 1,811,996 |
Long term debt | 26,608,122 | 26,981,372 | 47,357,394 | 31,722,000 |
Total liabilities | 31,287,656 | 35,041,862 | 52,203,859 | 33,533,996 |
Contributed capital | 12,680,425 | 20,157,325 | 15,069,392 | 10,258,293 |
Retained earnings | 0 | 0 | 0 | -1,838,410 |
Total equity | 12,680,425 | 20,157,325 | 15,069,392 | 8,419,883 |
Total equity and liabilities | 43,968,081 | 55,199,187 | 67,273,250 | 41,953,878 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises